Insider Transactions in Q4 2025 at Kyverna Therapeutics, Inc. (KYTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2025
|
Westlake Bio Partners Opportunity Fund I, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
133,333
+13.3%
|
$933,331
$7.5 P/Share
|
|
Dec 18
2025
|
Beth C Seidenberg Director |
BUY
Open market or private purchase
|
Indirect |
133,333
+13.3%
|
$933,331
$7.5 P/Share
|
|
Dec 15
2025
|
Karen Marie Walker Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
23,998
-51.46%
|
$287,976
$12.2 P/Share
|
|
Dec 15
2025
|
Karen Marie Walker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,998
+33.98%
|
$95,992
$4.83 P/Share
|